The GLIDE program, created by ARPA-H, is seeking proposals to develop innovative therapies and interventions for lymphatic dysfunction. This initiative is designed to address both primary lymphatic diseases
The GLIDE program, created by ARPA-H, is seeking proposals to develop innovative therapies and interventions for lymphatic dysfunction. This initiative is designed to address both primary lymphatic diseases and chronic conditions associated with lymphatic issues. The program is open to universities, non-profits, and small businesses.
The proposal submission deadline is October 31st 2024. For more details on the program and requirements click here.
October 31, 2024 12:59 am(GMT-05:00)